ADCT-701

· ADC Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ADCT-701, covering 2026-03-27 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors [Phase 1]

See pricing